Compare CVS Health Corp (CVS) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Cytokinetics Inc — how do they compare? CVS Health Corp trades at $96.74 (market cap $123.73B), while Cytokinetics Inc trades at $72.72 (market cap $10.11B). The key difference: CVS Health Corp is far larger — about 12.2× Cytokinetics Inc's market cap, and CVS Health Corp pays a 2.75% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CVS | CYTK | |
|---|---|---|
Market Cap | $123.73B | $10.11B |
Sector | Health | Technology |
52-Week High | $110.60 | $87.26 |
52-Week Low | $70.08 | $47.56 |
Enterprise Value | $186.08B | $10.21B |
Dividend Yield | 2.75% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
